Octavius Pharma has developed DC granules of Sacubitril + Valsartan for making Sacubitril + Valsartan tablets. The product has been developed to ensure a proper dissolution profile throughout shelf life. Finished tablet specifications and dissolution profile comply as per IH specification.
| Strength | 24 + 26 / 49 + 51 / 97 + 103 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | IH |
| API DMF | Available |
| CTD Dosssier | Under Development |
Sacubitril + Valsartan: Sacubitril + Valsartan is a fixed-dose combination medication for use in heart failure. It belongs to a class of Angiotensin Receptor Neprilysin Inhibitor (ARNI), works by relaxing the blood vessels and making it easier for the heart to pump blood throughout the body. In addition, it also helps the body retain less water.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields